Biotech UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) Supports Expedited Review of Marketing Authorization Application for Sabizabulin Treatment in Hospitalized COVID-19 Patients July 25, 2022
Biotech Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) July 25, 2022
Biotech Prometheus Biosciences to Host a Virtual R&D Day for Analysts and Investors on July 26, 2022 July 22, 2022
Biotech Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 22, 2022
Biotech Prometheus Biosciences Completes Enrollment of the ARTEMIS-UC Cohort 1 Phase 2 Study in Ulcerative Colitis July 22, 2022